ANI PHARMACEUTICALS INC
ANIPNASDAQ🏆 #2132 by market capEarnings Nov 5US Equity
$72.95▲ $0.33 (+0.45%)
LiveTrack ANIP
Get earnings, price moves & breaking news on Telegram
24h▲ 0.5%
7d▼ 2.0%
14d▼ 1.0%
30d▼ 0.4%
ytd▼ 7.6%
1y▼ 20.5%
🏦Market Cap
$1.66B
Small Cap
📈Revenue Growth (YoY)
+43.8%
High Growth
📊Gross Margin
65.2%
High
💵FCF Margin
16.3%
Healthy
⚖️P/S Ratio
1.7x
Cheap
Otter Score
76
Good
ANI PHARMACEUTICALS INC
ANIPAnalyst Ratings
Price
$72.95
Total
10
Raised
1
Lowered
2
Avg PT
$99.50
H / L
$119 / $85
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Guggenheim | Reiterated | Buy | 2026-08-10 | $119.00 | +63.10% |
Canaccord Genuity | Reiterated | Hold | 2026-08-10 | $90.00 | +23.40% |
Truist Securities | Reiterated | Hold | 2025-10-09 | — | — |
JP Morgan | Reiterated | Overweight | 2025-09-24 | — | — |
HC Wainwright & Co. | Reiterated | Buy | 2025-09-17 | — | — |
Raymond James | Reiterated | Outperform | 2024-09-18 | $83.00 | +13.80% |
Cantor Fitzgerald | Downgraded | Overweight → Neutral | 2020-05-07 | — | — |
Oppenheimer | Reiterated | Outperform | 2016-08-05 | $85.00 | +16.50% |
Standpoint Research | Downgraded | Buy → Hold | 2016-05-24 | — | — |
Roth Capital | Upgraded | Neutral → Buy | 2015-09-28 | — | — |
Institution
Guggenheim
Reiterated · Buy · 2026-08-10
$119.00
+63.10%
Canaccord Genuity
Reiterated · Hold · 2026-08-10
$90.00
+23.40%
Truist Securities
Reiterated · Hold · 2025-10-09
—
—
JP Morgan
Reiterated · Overweight · 2025-09-24
—
—
HC Wainwright & Co.
Reiterated · Buy · 2025-09-17
—
—
Raymond James
Reiterated · Outperform · 2024-09-18
$83.00
+13.80%
Cantor Fitzgerald
Downgraded · Overweight → Neutral · 2020-05-07
—
—
Oppenheimer
Reiterated · Outperform · 2016-08-05
$85.00
+16.50%
Standpoint Research
Downgraded · Buy → Hold · 2016-05-24
—
—
Roth Capital
Upgraded · Neutral → Buy · 2015-09-28
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space